Drug discrimination history: Pigeons trained to discriminate opioids with activity at different receptor types

Experimental and Clinical Psychopharmacology

Volumn 6, Issue 2, 1998, Pages 139-148

  Picker, Mitchell J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BREMAZOCINE; BUTORPHANOL; FENTANYL; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG DISCRIMINATION; DRUG TOLERANCE; FEMALE; NONHUMAN; PIGEON;

ANIMALS; BENZOMORPHANS; BUTORPHANOL; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; GUINEA PIGS; MORPHINE; NARCOTICS; RECEPTORS, OPIOID;

EID: 0031776839     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.6.2.139     Document Type: Article

References (33)

1. Brandt, M. R., & France, C. P. (1996). Discriminative Stimulus effects of enadoline in pigeons. Journal of Pharmacology and Experimental Therapeutics, 277, 960-967.
2. Butelman, E. R., Winger, G., Zernig, G., & Woods, J. H. (1995). Butorphanol: Characterization of agonist and antagonist effects in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 272, 845-853.
3. Doty, P., Picker, M. J., & Dykstra, L. A. (1989). Differential cross-tolerance to opioid agonists in morphine-tolerant squirrel monkeys responding under a schedule of food presentation. European Journal of Pharmacology, 174, 171-180.
4. Dykstra, L. A. (1990). Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 254, 245-252.
5. Dykstra, L. A., Gmerek, D. E., Winger, G., & Woods, J. H. (1987). Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. Journal of Pharmacology and Experimental Therapeutics, 242, 413-420.
6. France, C. P., Medzihradsky, F., & Woods, J. H. (1994). Comparison of kappa opioids in rhesus monkeys: Behavioral effects and receptor binding affinities. Journal of Pharmacology and Experimental Therapeutics, 268, 47-58.
7. Hayes, A. G., Sheehan, M. J., & Tyers, M. B. (1987). Differential sensitivity of models of antinociception in the rat, mouse and guinea pig to μ- and κ-opioid receptor agonists. British Journal of Pharmacology, 91, 823-832.
8. Horan, P., & Ho, I. K. (1989). Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacology Biochemistry & Behavior, 34, 847-854.
9. Leander, J. D. (1983). Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a κ-opioid receptor. European Journal of Pharmacology, 86, 467-470.
10. McMillan, D. E., Sun, W.-L., & Hardwick, W. C. (1996). Effects of drug discrimination history on the generalization of pentobarbital to other drugs. Journal of Pharmacology and Experimental Therapeutics, 278, 50-61.
11. Morris, B. J., & Herz, A. (1989). Control of opiate receptor number in vivo: Simultaneous κ-receptor down-regulation and μ- receptor up-regulation following chronic agonist/antagonist treatment. Neuroscience, 29, 433-442.
12. Nierenberg, J., & Ator, N. A. (1990). Drug discrimination in rats successively trained to discriminate diazepam and pentobarbital. Pharmacology Biochemistry and Behavior, 35, 405-412.
13. Overton, D. A., Merkle, D. A., & Hayes, M. L. (1983). Are "no-drug" cues discriminated during drug-discrimination training? Animal Learning & Behavior, 11, 295-301.
14. Paronis, C. A., & Holtzman, S. G. (1991). Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. Journal of Pharmacology and Experimental Therapeutics, 259, 582-598.
15. Paronis, C. A., & Holtzman, S. G. (1994). Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psychopharmacology, 114, 601-610.
16. Picker, M. J. (1994a). Discriminative stimulus and response rate-decreasing effects of kappa opioids: Antagonism by naloxone. Life Science, 54, 1767-1775.
17. Picker, M. J. (1994b). Kappa agonist and antagonist effects of mixed action opioids in a pigeon drug discrimination procedure. Journal of Pharmacology and Experimental Therapeutics, 268, 1190-1198.
18. Picker, M. J. (1995). Assessment of the kappa agonist and antagonist effects of mixed action opioids, mu opioids and a delta opioid in pigeons. Experimental and Clinical Psychopharmacology, 3, 240-251.
19. Picker, M. J., Benyas, S., Horwitz, J. A., Thompson, K., Mathewson, C., & Smith, M. A. (1996). Discriminative stimulus effects of butorphanol: Influence of training dose on the substitution patterns produced by mu, kappa and delta opioid agonists. Journal of Pharmacology and Experimental Therapeutics, 279, 1130-1141.
20. Picker, M. J., & Dykstra, L. A. (1987). Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons. Journal of Pharmacology and Experimental Therapeutics, 243, 938-945.
21. Picker, M. J., & Dykstra, L. A. (1989). Discriminative stimulus properties of mu and kappa opioids in the pigeon: Analysis of the effects of full and partial mu and kappa agonists. Journal of Pharmacology and Experimental Therapeutics, 249, 557-566.
22. Picker, M. J., Yarbrough, J., Hughes, C. E., Smith, M. A., Morgan, D., & Dykstra, L. A. (1993). Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: Role of training dose, intrinsic efficacy and inter-animal differences. Journal of Pharmacology and Experimental Therapeutics, 266, 756-767.
23. Schulz, R., & Wuster, M. (1981). Are there subtypes (isoreceptors) of multiple opiate receptors in the mouse vas deferons? European Journal of Pharmacology, 76, 61-66.
24. Shannon, H. E., & Holtzman, S. G. (1977). Further evaluation of the discriminative effects of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics, 201, 55-66.
25. Shearman, G. T., & Herz, A. (1981). Discriminative stimulus properties of bremazocine in the rat. Neuropharmacology, 20, 1209-1213.
26. Vanecek, S. E., & Young, A. M. (1995). Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behavioural Pharmacology, 6, 669-681.
27. VonVoigtlander, P. F., & Lewis, R. A. (1988). Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. Journal of Pharmacology and Experimental Therapeutics, 246, 259-262.
28. 2 analysis in assessment of opioid abuse liability. Trends in Pharmacological Science, 13, 282-296.
29. Yoburn, B. C., Shah, S., Chan, K., Duttaroy, A., & Davis, T. (1995). Supersensitivity of opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacology Biochemistry and Behavior, 51, 535-539.
30. Young, A. M. (1991). Discriminative stimulus profiles of psychoactive drugs. In N. K. Mello (Ed.), Substance abuse, behavioral and biological research (Vol. 4, pp. 139-203). London: Jessica Kingsley Publishers.
31. Young, A. M., Sannerud, C. A., Steigerwald, E. S., Doty, M. D., Lipinski, W. J., & Tetrick, L. E. (1990). Tolerance to morphine stimulus control: Role of morphine maintenance dose. Psychopharmacology, 102, 59-67.
32. Young, A. M., Steigerwald, E. S., Makhay, M., & Kapitsopoulos, G. (1991). Onset of tolerance to discriminative stimulus effects of morphine. Pharmacology Biochemistry & Behavior, 39, 487-493.
33. Young, A. M., Walton, M. A., & Carter, T. L. (1992). Selective tolerance to discriminative stimulus effects of morphine or d-amphetamine. Behavioural Pharmacology, 3, 210-209.